Medtronic PLC (2M6) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (2M6) has a cash flow conversion efficiency ratio of 0.056x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.75 Billion ≈ $3.21 Billion USD) by net assets (€49.24 Billion ≈ $57.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medtronic PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AXA SA
PA:CS
|
0.131x |
|
Adobe Systems Incorporated
NASDAQ:ADBE
|
0.259x |
|
Comcast Corp
NASDAQ:CMCSA
|
0.078x |
|
Equinor ASA
OL:EQNR
|
0.494x |
|
MercadoLibre Inc.
NASDAQ:MELI
|
0.285x |
|
Ping An Insurance Group Co of China Ltd
SHG:601318
|
0.001x |
|
Snowflake Inc.
NYSE:SNOW
|
0.125x |
|
CSX Corporation
NASDAQ:CSX
|
0.094x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2025)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Medtronic PLC.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | €48.26 Billion ≈ $56.42 Billion |
€7.04 Billion ≈ $8.24 Billion |
0.146x | +8.44% |
| 2024-04-30 | €50.42 Billion ≈ $58.95 Billion |
€6.79 Billion ≈ $7.93 Billion |
0.135x | +15.16% |
| 2023-04-30 | €51.66 Billion ≈ $60.40 Billion |
€6.04 Billion ≈ $7.06 Billion |
0.117x | -16.11% |
| 2022-04-30 | €52.72 Billion ≈ $61.64 Billion |
€7.35 Billion ≈ $8.59 Billion |
0.139x | +15.22% |
| 2021-04-30 | €51.60 Billion ≈ $60.33 Billion |
€6.24 Billion ≈ $7.30 Billion |
0.121x | -14.96% |
| 2020-04-30 | €50.87 Billion ≈ $59.47 Billion |
€7.23 Billion ≈ $8.46 Billion |
0.142x | +1.90% |
| 2019-04-30 | €50.21 Billion ≈ $58.70 Billion |
€7.01 Billion ≈ $8.19 Billion |
0.140x | +51.41% |
| 2018-04-30 | €50.82 Billion ≈ $59.42 Billion |
€4.68 Billion ≈ $5.48 Billion |
0.092x | -32.46% |
| 2017-04-30 | €50.42 Billion ≈ $58.94 Billion |
€6.88 Billion ≈ $8.04 Billion |
0.136x | +35.54% |
| 2016-04-30 | €51.83 Billion ≈ $60.59 Billion |
€5.22 Billion ≈ $6.10 Billion |
0.101x | +9.33% |
| 2015-04-30 | €53.23 Billion ≈ $62.23 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.092x | -63.89% |
| 2014-04-30 | €19.44 Billion ≈ $22.73 Billion |
€4.96 Billion ≈ $5.80 Billion |
0.255x | -2.48% |
| 2013-04-30 | €18.67 Billion ≈ $21.83 Billion |
€4.88 Billion ≈ $5.71 Billion |
0.262x | +2.16% |
| 2012-04-30 | €17.11 Billion ≈ $20.01 Billion |
€4.38 Billion ≈ $5.12 Billion |
0.256x | +9.27% |
| 2011-04-30 | €15.97 Billion ≈ $18.67 Billion |
€3.74 Billion ≈ $4.37 Billion |
0.234x | -17.03% |
| 2010-04-30 | €14.63 Billion ≈ $17.10 Billion |
€4.13 Billion ≈ $4.83 Billion |
0.282x | -6.42% |
| 2009-04-30 | €12.85 Billion ≈ $15.02 Billion |
€3.88 Billion ≈ $4.53 Billion |
0.302x | -0.22% |
| 2008-04-30 | €11.54 Billion ≈ $13.49 Billion |
€3.49 Billion ≈ $4.08 Billion |
0.302x | +11.44% |
| 2007-04-30 | €10.98 Billion ≈ $12.83 Billion |
€2.98 Billion ≈ $3.48 Billion |
0.271x | +15.35% |
| 2006-04-30 | €9.38 Billion ≈ $10.97 Billion |
€2.21 Billion ≈ $2.58 Billion |
0.235x | -12.80% |
| 2005-04-30 | €10.45 Billion ≈ $12.22 Billion |
€2.82 Billion ≈ $3.30 Billion |
0.270x | -13.94% |
| 2004-04-30 | €9.08 Billion ≈ $10.61 Billion |
€2.85 Billion ≈ $3.33 Billion |
0.314x | +19.28% |
| 2003-04-30 | €7.91 Billion ≈ $9.24 Billion |
€2.08 Billion ≈ $2.43 Billion |
0.263x | +6.30% |
| 2002-04-30 | €6.43 Billion ≈ $7.52 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.247x | -25.62% |
| 2001-04-30 | €5.51 Billion ≈ $6.44 Billion |
€1.83 Billion ≈ $2.14 Billion |
0.332x | +43.29% |
| 2000-04-30 | €4.49 Billion ≈ $5.25 Billion |
€1.04 Billion ≈ $1.22 Billion |
0.232x | +86.22% |
| 1999-04-30 | €3.65 Billion ≈ $4.27 Billion |
€455.30 Million ≈ $532.29 Million |
0.125x | -56.84% |
| 1998-04-30 | €2.04 Billion ≈ $2.39 Billion |
€590.10 Million ≈ $689.89 Million |
0.289x | +8.73% |
| 1997-04-30 | €1.75 Billion ≈ $2.04 Billion |
€463.60 Million ≈ $542.00 Million |
0.265x | -5.09% |
| 1996-04-30 | €1.79 Billion ≈ $2.09 Billion |
€500.50 Million ≈ $585.14 Million |
0.280x | -3.56% |
| 1995-04-30 | €1.33 Billion ≈ $1.56 Billion |
€387.20 Million ≈ $452.68 Million |
0.290x | -14.39% |
| 1994-04-30 | €1.05 Billion ≈ $1.23 Billion |
€356.90 Million ≈ $417.25 Million |
0.339x | -2.20% |
| 1993-04-30 | €841.50 Million ≈ $983.80 Million |
€291.50 Million ≈ $340.79 Million |
0.346x | +82.24% |
| 1992-04-30 | €796.50 Million ≈ $931.19 Million |
€151.40 Million ≈ $177.00 Million |
0.190x | +2.58% |
| 1991-04-30 | €683.20 Million ≈ $798.73 Million |
€126.60 Million ≈ $148.01 Million |
0.185x | -6.13% |
| 1990-04-30 | €541.00 Million ≈ $632.49 Million |
€106.80 Million ≈ $124.86 Million |
0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more